Fundamental dimension Equity attribute | ARCUFLeader $1.000.00% Cap $7.39MP/E -37.3x QuantScore48/100 | CYNXFPeer $0.04240.00% Cap $953.6KP/E -0.8x QuantScore19/100 | EGMLFPeer $0.04270.00% Cap $1.25MP/E -4.5x QuantScore27/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
49/100 |
56/100 |
23/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 0/100 | 25/100 |
Health Piotroski, Altman Z, leverage & liquidity | 60/100 | 20/100 | 23/100 |
Growth Revenue / earnings growth & margins | 50/100 | 0/100 | 39/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -37.3x | -0.8x | -4.5x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -11.6x | -3.1x | -6.7x |
Price / Sales | — | — | — |
Price / Free Cash Flow | -30.5x | -6.1x | 444.3x |
PEG ratio | 0.34 | -0.01 | 0.03 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 2 / 9 | 3 / 9 |
Altman Z-Score | 40.26 (Safe) | -1659.97 (Distress) | -0.25 (Distress) |
Total debt / equity | 0.00 | -0.08 | 0.06 |
Quick ratio | 22.8x | 0.0x | 0.0x |
Interest coverage | -2184.0x | -10.0x | -9.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | — |
Net income growth YoY | +54.1% | -60.3% | +36.2% |
Gross margin (TTM) | 0.0% | 0.0% | 0.0% |
Operating margin (FY) | — | — | — |
FCF margin (FY) | — | — | — |
5. Trailing price performancePrice change over period |
1M return | 0.0% | 0.0% | -33.3% |
3M return | +900.0% | 0.0% | -34.6% |
6M return | +900.0% | -15.9% | -49.9% |
Year to date | +900.0% | -15.9% | +72.9% |
1Y return | +19900.0% | -15.9% | +72.9% |
3Y return | +9900.0% | -91.4% | +68.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.014 -101.4% premium | $-0.00 -100.1% premium | $-0.0111 -126.0% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |